Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABA agonist: clomethiazole.

Anand Vaishnav1, Helmi L Lutsep

  • 1Oregon Stroke Center, Oregon Health Sciences University, Portland 97201, USA.

Current Medical Research and Opinion
|October 9, 2002
PubMed
Summary

Clomethiazole, a neuroprotective agent, failed to outperform placebo in human trials despite promising animal model results for treating brain ischaemic injury. This GABA(A) agonist did not demonstrate clinical efficacy in large-scale studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Masculinization and physiological responses of rosy barb, Pethia conchonius to combined hormonal treatment.

Scientific reports·2025
Same author

Revolutionizing Stroke Management with Wearable Technology: A Narrative Review of Clinical Applications, Opportunities, Challenges, and the Future Path Towards Equitable Implementation.

Annals of Indian Academy of Neurology·2025
Same author

SPRINT INDIA: Regional Variations in Primary and Secondary Stroke Outcomes Based on Baseline Characteristics in North and South Indian Sites.

Annals of Indian Academy of Neurology·2025
Same author

Comparing Stroke Profiles and Outcomes between Urban and Rural India: A Secondary Analysis of the SPRINT INDIA Trial.

Cerebrovascular diseases (Basel, Switzerland)·2025
Same author

Unlocking the potential of fishery waste: exploring diverse applications of fish protein hydrolysates in food and nonfood sectors.

Environmental science and pollution research international·2025
Same author

Formaldehyde contamination in seafood industry: an update on detection methods and legislations.

Environmental science and pollution research international·2024

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Neuroprotective agents aim to prevent neuronal death during brain ischaemic injury.
  • Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter counteracting glutamate excitotoxicity.
  • Clomethiazole acts as a GABA(A) agonist, promoting hyperpolarization to inhibit neuronal death cascades.

Purpose of the Study:

  • To evaluate the efficacy of clomethiazole as a neuroprotective agent in human clinical trials.
  • To determine if clomethiazole's promising results in animal models translate to human patients experiencing ischaemic injury.

Main Methods:

  • Conducting large-scale, randomized, placebo-controlled clinical trials in Europe, Canada, and North America.
  • Administering clomethiazole to human subjects experiencing brain ischaemic injury.
  • Comparing patient outcomes between the clomethiazole group and the placebo group.

Main Results:

  • Clomethiazole did not demonstrate superiority over placebo in large human clinical trials.
  • The neuroprotective effects observed in animal models were not replicated in human studies.
  • Clinical efficacy of clomethiazole for brain ischaemic injury was not established.

Conclusions:

  • Clomethiazole is not superior to placebo for treating brain ischaemic injury in humans.
  • Translating animal model findings to human clinical efficacy for neuroprotection remains a challenge.
  • Further research may be needed to identify effective neuroprotective strategies for ischaemic stroke.

Related Experiment Videos